Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dri-c21045 showed concentration-dependent inhibition of NF-kB activation and all CD40L induced by B cell proliferation with IC50 of 17.1 μM and 4.5 μM, respectively. Dri-c21045 is an effective selective inhibitor of CD40-CD40L synergistic stimulator protein-protein interaction (PPI) with IC50 of 0.17 μM.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 7,500 | |||
2 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 16,500 | |||
10 mg | 在庫あり | ¥ 28,000 | |||
25 mg | 在庫あり | ¥ 53,500 | |||
50 mg | 在庫あり | ¥ 95,000 | |||
100 mg | 在庫あり | ¥ 142,000 |
説明 | Dri-c21045 showed concentration-dependent inhibition of NF-kB activation and all CD40L induced by B cell proliferation with IC50 of 17.1 μM and 4.5 μM, respectively. Dri-c21045 is an effective selective inhibitor of CD40-CD40L synergistic stimulator protein-protein interaction (PPI) with IC50 of 0.17 μM. |
ターゲット&IC50 | CD40:0.17 µM |
分子量 | 580.61 |
分子式 | C32H24N2O7S |
CAS No. | 2101765-81-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2 mg/mL (3.44 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DRI-C21045 2101765-81-3 NF-Κb NF-κB DRI C21045 Tumor Necrosis Factor Receptor DRIC21045 Inhibitor TNFR DRI-C 21045 DRI-C-21045 inhibit TNF Receptor inhibitor